0001477449-23-000107.txt : 20231205 0001477449-23-000107.hdr.sgml : 20231205 20231205160807 ACCESSION NUMBER: 0001477449-23-000107 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231201 FILED AS OF DATE: 20231205 DATE AS OF CHANGE: 20231205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jensen Claus Torp CENTRAL INDEX KEY: 0001857993 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 231466632 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 4 1 wk-form4_1701810473.xml FORM 4 X0508 4 2023-12-01 1 0001477449 Teladoc Health, Inc. TDOC 0001857993 Jensen Claus Torp C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577 0 1 0 0 CHIEF INNOVATION OFFICER 0 Common Stock 2023-12-01 4 M 0 2807 A 18660 D Common Stock 2023-12-01 4 M 0 2043 A 20703 D Restricted Stock Units 2023-12-01 4 M 0 2807 0 D Common Stock 2807 14038 D Restricted Stock Units 2023-12-01 4 M 0 2043 0 D Common Stock 2043 12264 D Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. On March 1, 2022, the reporting person was granted 33,688 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. On June 1, 2022, the reporting person was granted 24,525 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. /s/ Adam C. Vandervoort, Attorney-in-Fact 2023-12-05